DP
Congress trade
Sen. David Perdue (R-GA) bought $15K-$50K of Pfizer Inc. (PFE) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of Pfizer Inc. (PFE) stock worth $15K-$50K in a STOCK Act filing on May 2, 2021.
The trade happened on Feb 27, 2020, 430 days before it was made public.
PFE has moved -8.6% since the trade date, from $32.35 to $29.58 (Oct 16, 2026 close).
- Traded
- Feb 27, 2020
- Disclosed
- May 2, 2021
- Filing delay
- 430 days
- Price since
- -8.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyDAL$15K-$50KMay 2, 2021
- BuyPFE$15K-$50KMay 2, 2021
- BuyPFE$15K-$50KMay 2, 2021
- BuyPFE$15K-$50KMay 2, 2021
- BuyT$15K-$50KMay 2, 2021
- SellT$15K-$50KMay 2, 2021
- SellT$15K-$50KMay 2, 2021
- SellAAPL$1K-$15KMay 2, 2021
- SellALB$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellCZR$1K-$15KMay 2, 2021
- SellDCP$1K-$15KMay 2, 2021
- SellDCP$1K-$15KMay 2, 2021
- BuyDD$1K-$15KMay 2, 2021
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.